Unichem Laboratories share news and announcements
NSE: UNICHEMLABBSE: 506690Pharmaceuticals & BiotechnologySmall Cap
Last close ₹472.95down ₹14.80 (3.03%)BSE ₹471.95
Share price at the NSE close on 23 Oct 2026. Previous close ₹487.75.
52-week range of traded prices to 23 Oct 2026
₹278.20Low, 30 Mar 2026₹687.20High, 9 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3,330 Cr1,036th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 10.9
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹205 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 33.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 22 May 2026
- 1.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 11.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹205 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 22 May 2026
- 0.17
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 40,08440.7% delivered
Unichem Laboratories share news and announcements
717 announcements, routine notices left out, newest first. Page 11 of 15.
Dec 2014
12 Dec · Legal
Exchange had sought clarification from Unichem Laboratories Limited with respect to a news item captioned "Germany bans 80 generic drugs for insufficient trials". The Company has clarified that "We have been aware of the concerns with GVK Biosciences and have been cooperating with the European authorities, via our subsidiary Unichem Ireland. Of the products referred to, none of them are currently on sale in Germany from Unichem, therefore this action will have no material impact on the overall performance of Unichem Laboratories Limited".11 Dec · Legal
Exchange has sought clarification from Unichem Laboratories Limited with respect to recent news item captioned "Germany bans 80 generic drugs for insufficient trials". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any information that has not been announced to the Exchanges under clause 36 of the Listing Agreement. The response from the Company is awaited.
Nov 2014
Oct 2014
7 Oct · Board meeting
Inter alia, to consider and take on record Un-Audited Accounts for the quarter and half year ended September 30, 2014.Further, that pursuant to the Code of Conduct adopted by the Company under SEBI(Prohibition of Insider Trading) Regulations, 1992, the Trading Window for dealing in the equity shares of the Company will remain closed from October 08, 2014 to October 18, 20147 (both days inclusive) and shall open 24 hours after said financial results are made public. Accordingly, Directors / Designated employees shall not trade in the equity shares of the Company during the above said period.
Sep 2014
Jul 2014
15 Jul · Disclosure of Voting Pattern - Clause 35A
15 Jul · Disclosure of Voting Pattern - Clause 35A
9 Jul · Business
Jun 2014
18 Jun · Updates
1. In terms of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management & Administration) Rules, 2014, the Company has fixed May 30, 2014. as the cut-off date for entitlement of Members to cast their votes electronically for the businesses to be transacted at the ensuing 51st Annual General Meeting (AGM) of the Company, to be held on July 12, 2014. The Company has entered into agreement with Central Depository Services Limited for availing the E-Voting Services.2. The Annual Report of the Company together with the Notice of Annual General Meeting is sent to the shareholders of the Company at their registered address/ e-mail ID on June 16, 2014. 3. The final dividend of Rs. 4/- (200%) per equity share having a face value of Rs.2/-, if approved by the shareholders at the ensuing Annual General Meeting of the Company scheduled to be held on July 12, 2014, shall be dispatched to the shareholders on and from July 17. 2014.
May 2014
16 May · Board meeting
Board of Directors of the Company at its meeting held on May 10, 2014, has considered the following: (1) Recommended the Appointment of B.D, Jokhakar & Co. as statutory auditors of the Company for period of three consecutive years from the conclusion of the ensuing Annual General Meeting subject to the approval of the Shareholders at the ensuing AGM.13 May · Meeting
Company has fixed Book Closure from July 7, 2014 to July 12, 2014 (both days inclusive) for the purpose of Dividend and Annual General Meeting to be held on July 12, 2014.13 May · Board meeting
Board of Directors of the Company at its meeting held on May 10, 2014, inter alia, has also considered the following: 1) Appointment of Mr. Prafull Anubhai, Mr. Ramdas M. Gandhi, Mr. Nasser Munjee, Mr. Prafull D. Sheth and Mr. Anand Mahajan existing Independent Directors, as Independent Directors of the Company, for a term of 5 consecutive years starting from July 12, 2014 subject to approval of the shareholders at the ensuing AGM. 2) Recommended the Appointment of B. D. Jokhakar & Co., as statutory auditors of the Company for a period of three consecutive years from the conclusion of the ensuing Annual General Meeting, subject to the approval of the shareholders at the ensuing AGM.13 May · Board meeting
Board of Directors of the Company in its meeting held on March 10, 2014, allotted and issued 30,250 equity shares of Rs. 2/- each pursuant to exercise of the stock options by the eligible employees under the Employee Stock Option Scheme 2008 of the company.12 May · Dividend
Board of Directors of the Company at its meeting held May 10, 2014 has recommended Final Dividend of Rs.4/- (200%) per equity share of Rs.2/- each for the financial year 2013-14, subject to the approval of the shareholders at the forthcoming Annual General Meeting.
Apr 2014
28 Apr · Board meeting
Inter-alia, to consider and take on record the Audited Accounts for the year ended March 31, 2014 and recommendation of final dividend if any.
Mar 2014
10 Mar · Business
As required under Securities and Exchange Board of India (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999, the Compensation Committee of the Board of Directors of the Company in its meeting held on March 08, 2014 has granted 2,25,000/- (Two Lac Twenty Five Thousand) equity shares to the Employees of the Company in terms of its Employee Stock Option Scheme - 2008.Against each option, the grantee will have a right to apply for and get allotted one equity share at an exercise price of Rs. 46/- (Rupees Forty Six Only). The vesting period for the said option is a graded manner over five years as prescribed in the approved existing Scheme.
Jan 2014
20 Jan · Dividend
Board of Directors of the Company at its meeting held on January 18, 2014 has declared Interim dividend of Rs.4/- (200%) per equity share of Rs.2/- each for the financial year 2013-14.8 Jan · Corporate action
Company has fixed Record Date as January 24, 2014 for the purpose of payment of Interim Dividend, if any declared by the Board.8 Jan · Dividend
January 29, 2014 has been fixed as date of payment of Interim Dividend, if declared.8 Jan · Business
Board has approved allotment of 7,600 equity shares through circular resolution on January 08, 2014 pursuant to exercise of the stock options by the eligible employees under the Employee Stock Option Scheme 2004 & Employee Stock Option Scheme 2008 of the Company.6 Jan · Board meeting
Inter-alia, to consider and take on record Un-Audited Accounts for the quarter ended December 31, 2013 and to consider interim dividend, if any for the financial year 2013-14.
Oct 2013
24 Oct · Business
Board of Directors in its meeting held on October 19, 2013 allotted and issued 10,625 equity shares of Rs. 2/-each pursuant to exercise of the stock options by the eligible employees under the Employees Stock Option Scheme 2008 of the Company.